Class 4 Drug Caution In Use - Beclometasone dipropionate 50 micrograms/dose Nasal Spray (Various Liveries)

Ayrton Saunders Limited have identified an error relating to the Braille printed on the cartons.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-ayrton-saunders-limited-beclometasone-dipropionate-50-micrograms-slash-dose-nasal-spray-various-liveries-el-22-a-slash-14?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=3cee273e-9974-4dab-91dc-ef9076df844b&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For medical information and stock control queries please contact: Ayrton Saunders Ltd., 9 Arkwright Road, Astmoor Industrial Estate, Runcorn, Cheshire, WA7 1NU or quality@ayrtons.com

Class 4 Drug Caution In Use - Latuda film-coated tablets

CNX Therapeutics Ltd. have notified the MHRA that the batches of Latuda film-coated tablets listed in this notification will be released without EAN barcodes on the cartons.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-cnx-therapeutics-ltd-latuda-film-coated-tablets-el-22-a-slash-13?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=dac1ea2a-e6e3-4479-b1e3-e8b6894509b8&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For more information and medical information contact: medinfo@cnx-therapeutics.com

For stock control queries please contact: supplychain@cnx-therapeutics.com

Class 2 Recall - Diazepam Rectubes 2.5mg Rectal Solution

Wockhardt UK Ltd are recalling a batch of Diazepam RecTubes 2.5mg Rectal Solution due to an out of specification result for assay during routine stability testing.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-wockhardt-uk-ltd-diazepam-rectubes-2-dot-5mg-rectal-solution-el-22-a-slash-11?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=ebb2ea59-2e04-4d36-ae96-7a763b1bac0f&utm_content=immediately

Further Information

For more information, medical or supply enquiries, please contact: drug.safety@wockhardt.co.uk

For stock control queries, please contact: customer.services@wockhardt.co.uk

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 3 Recall - Isotard 60mg XL Tablets X 28

Kyowa Kirin Services Ltd are recalling the below batch of Isotard 60mg XL Tablets as a precautionary measure due to microfibres/crystals of the Active Pharmaceutical Ingredient (API) being present on the surface of the tablets as a result of sublimation.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-kyowa-kirin-services-ltd-isotard-60mg-xl-tablets-el-22-a-slash-10?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=b4f8ccdb-aa09-4628-ba52-819224d0c0b3&utm_content=immediately

Further Information

For more information please contact:

Customer Services for stock control enquiries: Karen Murray karen.murray@kyowakirin.com +44 (0) 7712 001288 (Mobile)

Quality enquiries Martin Smith martin.smith@kyowakirin.com +44 (0)7904 671 807 (Mobile)

or for Medical Information enquiries: medinfo@kyowakirin.com

For Adverse Event reporting: medinfo@kyowakirin.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 Drug Caution In Use - Naprosyn Tablets (All Strengths), Naprosyn EC 250mg Gastro-Resistant Tablets, Naprosyn EC 500mg Gastro-Resistant Tablets

Atnahs Pharma UK Limited have identified additional missing information on the PIL of the certain product batches.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-atnahs-pharma-uk-limited-naprosyn-tablets-all-strengths-naprosyn-ec-500mg-gastro-resistant-tablets-el-22-a-slash-09?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=d1fe57c1-88a3-444b-acd2-2e861aa3fac2&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For medical information queries or stock control queries, please contact: info@pharmanovia.com

If you have any questions, then please contact your local Service Centre Customer Services team.

CLASS 4 CAUTION IN USE - NAPROSYN TABLETS (ALL STRENGTHS), NAPROSYN EC 500MG GASTRO-RESISTANT TABLETS

Additional to the batches included in the previous Class 4 Medicines Notification (reference EL(22)A/05), Atnahs Pharma UK Limited have informed us that the Patient Information Leaflets (PILs) in the above batches are missing information

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-atnahs-pharma-uk-limited-naprosyn-tablets-all-strengths-naprosyn-ec-500mg-gastro-resistant-tablets-el-22-a-slash-09?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=bf8465ff-1733-4206-8118-29be77b0cde5&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For medical information queries or stock control queries, please contact: info@pharmanovia.com

If you have any questions, then please contact your local Service Centre Customer Services team.

Company Led Recall - Alimentum and Elecare

Abbott Nutritional Ltd is recalling as a precautionary measure.

MHRA drug alert link: N/A

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

If you have any questions, then please contact your local Service Centre Customer Services team.

Class 2 Recall - Fluorouracil Injection, 50 mg/ml, solution for injection (2500mg/50ml vial)

Medac GmbH (t/a medac Pharma LLP) are recalling certain product batches as a precautionary measure due to visual detection of glass lamellae particles during an ongoing stability study.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-medac-gmbh-t-slash-a-medac-pharma-llp-fluorouracil-injection-50-mg-slash-ml-solution-for-injection-2500mg-slash-50ml-vial-el-22-a-08?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=72e19d5c-b6d8-4bd5-9cd1-ac0ab189f3d0&utm_content=immediately

Further Information

For more information, medical or supply enquiries, please contact Medac Pharma LLP by email to info@medacpharma.co.uk or telephone 01786 458086

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 2 Recall - Efudix 5% W/W Cream (2 X 20g) Pack

Uni Health Distribution is aware of a potential issue where the leaflet contained within Efudix 5% w/w cream (2 x 20g) pack, batch 80193439/B may be incorrect.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-uni-health-distribution-efudix-5-percent-w-slash-w-cream-el-22-a-07?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=17cc5756-8170-4e39-ac3b-145bbec7c060&utm_content=immediately

Alliance do not stock the above product so we will not be accepting Customer returns on this recall.

Further Information

For more information, please contact or email Margaret Fairney margaret@ennogen.com

For medical information queries, please contact or email Margaret Fairney margaret@ennogen.com

For supply queries, please contact Davide Rinaldi purchasing@ennogen.com

If you have any questions, then please contact your local Service Centre Customer Services team. 

Class 2 Recall - Water for injections 100ml x 25 vials

Hameln Pharma Ltd is recalling a batch of a product as a precautionary measure as remaining vials may no longer be in line with the licensed product specification.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-hameln-pharma-ltd-water-for-injections-bp-100ml-vial-el-22-a-06?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=a0cd0c19-6da8-4f3e-b4c1-e3e2fde990d1&utm_content=immediately

Further Information

For more information or supply queries, please contact or email Hameln pharma ltd customer services on +44 (0)1452 621 661 or customer.services@hameln-pharma.co.uk

For medical information queries, please contact or email Hameln pharma ltd Medicines Information on +44 (0)1452 621 661 or drug.safety@hameln-pharma.co.uk

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

If you have any questions, then please contact your local Service Centre Customer Services team.